Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Loss of biased signaling at a G protein-coupled receptor in overexpressed systems
Angus Li, Samuel Liu, Rennica Huang, et al.
PLoS ONE (2023) Vol. 18, Iss. 3, pp. e0283477-e0283477
Open Access | Times Cited: 23

Showing 23 citing articles:

Quantitative approaches for studying G protein-coupled receptor signalling and pharmacology
Abigail Pearce, Theo Redfern-Nichols, E. J. Wills, et al.
Journal of Cell Science (2025) Vol. 138, Iss. 1
Open Access | Times Cited: 2
Investigating selectivity and bias for G protein subtypes and β-arrestins by synthetic cannabinoid receptor agonists at the cannabinoid CB1 receptor
Beth Ryalls, Monica Patel, Eric Sparkes, et al.
Biochemical Pharmacology (2024) Vol. 222, pp. 116052-116052
Open Access | Times Cited: 9
Phosphoproteomics for studying signaling pathways evoked by hormones of the renin‐angiotensin system: A source of untapped potential
Igor Maciel Souza‐Silva, Victor Corasolla Carregari, U. Muscha Steckelings, et al.
Acta Physiologica (2025) Vol. 241, Iss. 2
Open Access | Times Cited: 1
Bias translation: The final frontier?
Terry Kenakin
British Journal of Pharmacology (2024) Vol. 181, Iss. 9, pp. 1345-1360
Open Access | Times Cited: 8
Know your molecule: pharmacological characterization of drug candidates to enhance efficacy and reduce late-stage attrition
Terry Kenakin
Nature Reviews Drug Discovery (2024) Vol. 23, Iss. 8, pp. 626-644
Closed Access | Times Cited: 8
What are the current trends in G protein-coupled receptor targeted drug discovery?
Vicent Casadó, Verònica Casadó-Anguera
Expert Opinion on Drug Discovery (2023) Vol. 18, Iss. 8, pp. 815-820
Open Access | Times Cited: 16
Flavors of GPCR signaling bias
Mohammad Seyedabadi, Vsevolod V. Gurevich
Neuropharmacology (2024), pp. 110167-110167
Closed Access | Times Cited: 5
In Vitro Signaling Properties of Cannabinoid and Orexin Receptors: How Orexin Receptors Influence Cannabinoid Receptor‐Mediated Signaling
Kawthar A. Mohamed, Robert B. Laprairie
Pharmacology Research & Perspectives (2025) Vol. 13, Iss. 2
Open Access
Characterization of the Molecular Mechanisms Underlying Lurasidone‐Induced Acute Manic Episodes in Bipolar Depression: A Network Pharmacology and Molecular Docking Approach
Chao Li, Lei Yang, Qiuyu Zhang, et al.
CNS Neuroscience & Therapeutics (2025) Vol. 31, Iss. 4
Open Access
Neurotensin and Alcohol Use Disorders: Towards a Pharmacological Treatment
Francisco D. Rodríguez, Manuel Lisardo Sánchez, Rafael Coveñas
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 10, pp. 8656-8656
Open Access | Times Cited: 9
Biased Agonism or “Biaism” for Dummies: A Commentary
Jean A. Boutin, Jérôme Leprince
Receptors (2024) Vol. 3, Iss. 1, pp. 13-26
Open Access | Times Cited: 3
Binding and unbinding of potent melatonin receptor ligands: Mechanistic simulations and experimental evidence
Annalida Bedini, Gian Marco Elisi, Fabiola Fanini, et al.
Journal of Pineal Research (2024) Vol. 76, Iss. 2
Open Access | Times Cited: 2
Human pluripotent stem cells as a translational toolkit in psychedelic research in vitro
José Alexandre Salerno, Stevens K. Rehen
iScience (2024) Vol. 27, Iss. 5, pp. 109631-109631
Open Access | Times Cited: 2
Phosphorylation patterns in the AT1R C-terminal tail specify distinct downstream signaling pathways
Clarice Gareri, Conrad T. Pfeiffer, Xue Jiang, et al.
Science Signaling (2024) Vol. 17, Iss. 849
Open Access | Times Cited: 2
Diverse pathways in GPCR-mediated activation of Ca2+ mobilization in HEK293 cells
Francesco De Pascali, Asuka Inoue, Jeffrey Benovic
Journal of Biological Chemistry (2024) Vol. 300, Iss. 11, pp. 107882-107882
Closed Access | Times Cited: 2
Functional bias of contractile control in mouse resistance arteries
Nadia Haghbin, David M. Richter, Sanjay Kharche, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 1
Synthesis and Pharmacological Characterization of Fluorescent Ligands Targeting the Angiotensin II Receptors Derived from Agonists, β-Arrestin-Biased Agonists, and Antagonists
Céline Delaitre, Michel Boisbrun, Samir Acherar, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 22, pp. 20275-20297
Closed Access | Times Cited: 1
β-adrenergic receptor signaling mediated by β-arrestins and its potential role in heart failure
Preston C. Nibley, Sudha K. Shenoy
Current Opinion in Physiology (2023) Vol. 37, pp. 100723-100723
Open Access | Times Cited: 3
Allosteric Sites and Allosteric Regulators of G Protein-Coupled Receptors: Gray Cardinals of Signal Transduction
А. О. Шпаков
Journal of Evolutionary Biochemistry and Physiology (2023) Vol. 59, Iss. S1, pp. S1-S106
Closed Access | Times Cited: 2
ALLOSTERIC SITES AND ALLOSTERIC REGULATORS OF G-PROTEIN-COUPLED RECEPTORS: GRAY CARDINALS OF SIGNAL TRANSDUCTION
А. О. Шпаков
Журнал эволюционной биохимии и физиологии (2023) Vol. 59, Iss. 7, pp. 559-658
Closed Access | Times Cited: 1
Multiple triggers converge to preferential effector coupling in the CB2R through a complex allosteric communication network
Adrián Morales-Pastor, Tamara Miljuš, Tomasz Maciej Stępniewski, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Small Molecule Modulators of Beta-arrestins
Alem W. Kahsai, Natalia Pakharukova, Henry Y. Kwon, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Bias Translation: The Final Frontier?
Terry Kenakin
Authorea (Authorea) (2023)
Open Access
Page 1

Scroll to top